Synonym
Eclanamine maleate; U-48,753E; U48,753E; U 48,753E; U-48753E; U48753E; U 48753E.
IUPAC/Chemical Name
N-(3,4-dichlorophenyl)-N-[(1R,2R)-2-(dimethylamino)cyclopentyl]-propanamide maleate
InChi Key
ZEUQHGFLDLNEOB-CHHFXETESA-N
InChi Code
InChI=1S/C16H22Cl2N2O.C4H4O4/c1-4-16(21)20(11-8-9-12(17)13(18)10-11)15-7-5-6-14(15)19(2)3;5-3(6)1-2-4(7)8/h8-10,14-15H,4-7H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t14-,15-;/m1./s1
SMILES Code
CCC(N(C1=CC=C(Cl)C(Cl)=C1)[C@H]2[C@H](N(C)C)CCC2)=O.O=C(O)/C=C\C(O)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Related CAS#
CAS#67450-45-7 (Eclanamine maleate)
CAS#67450-44-6 (Eclanamine free base)
Preparing Stock Solutions
The following data is based on the
product
molecular weight
445.34
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Aaron CS, Harbach PR, Mattano SS, Mayo JK, Wang Y, Yu RL, Zimmer DM. Risk and
benefit evaluation in development of pharmaceutical products. Environ Health
Perspect. 1993 Oct;101 Suppl 3:291-5. Review. PubMed PMID: 8143634; PubMed
Central PMCID: PMC1521120.
2: Aaron CS, Stankowski LF Jr, Harbach PR, Valencia R, Mayo JK, Mirsalis J,
Mazurek JH, Steinmetz KL, Wiser SK, Zimmer DM, et al. Comparative mutagenicity
testing of a drug candidate, U-48753E: mechanism of induction of gene mutations
in mammalian cells and quantitation of potential hazard. Mutat Res. 1989
Jun;223(2):111-20. PubMed PMID: 2500592.
3: Sethy VH, Day JS, Cooper MM. Dose-dependent down-regulation of beta-adrenergic
receptors after chronic intravenous infusion of antidepressants. Prog
Neuropsychopharmacol Biol Psychiatry. 1988;12(5):673-82. PubMed PMID: 2851860.